activity was determined using acetate buffer and p-nitrophenyl (PNP) sulfate (20 mM) as a substrate (Tabatabai and Bremner 1970).
Very low arylsulfatase
A and cerebroside sulfatase activities in leukocytes of healthy members of metachromatic leukodystrophy family.
Identification to species level was achieved on the basis of the growth characteristics, including growth in less than 7 days, growth at 37[degrees]C, growth in the presence of NaCl 5%, pigment production, Niacin production, pyrazinamidase, urease, nitrate reduction test, catalase test, heat-stable catalase (pH 7, 68[degrees]C), Tween 80 hydrolysis, growth on MacConkey agar, arylsulfatase
test, and colony morphology.
Activity of some hepatic enzymes in schistosomiasis and concomitant alteration of arylsulfatase
Early reports of DPHL suggested an associated deficiency of arylsulfatase
A, an enzyme required in the modulation of myelin; however, more recent case reports are conflicting.
Prevalence of anti-adeno-associated virus serotype 8 neutralizing antibodies and arylsulfatase
B cross-reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial.
Moreover, the 3 genomes we identified contain homologs of arylsulfatase
and genes that enable invasion of brain endothelial cells, which contribute to the ability of Escherichia coli to cross the blood-brain barrier in neonatal meningitis (32).
In a study of MPS-VI using DBS, all 7 MPS-VI patients displayed arylsulfatase
B protein and activity after immunocapture below the values for 32 controls (53).
Urease, L-glutaminase, L-asparaginase, alkaline phosphomonoesterase, and arylsulfatase
activities were determined in the rhizospheric soil according to the protocols described by Tabatabai [16, 17].
For example, the M fortuitum and M chelonae/M abscessus groups are strongly positive for the arylsulfatase
reaction at 3 days, in contrast to Mycobacterium wolinskyi and the M smegmatis group.
DSM's patent application for Maxilact[R] lactase, which is free from arylsulfatase
, has been granted in Europe.
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase
B or rhASB) and follow-on, open-label extension study.